User Tools

Site Tools


Intracranial aneurysm rebleeding

Aneurysm rerupture prior to treatment is a major cause of death and morbidity in aneurysmal subarachnoid hemorrhage.

see Intracranial aneurysm rerupture after treatment.

see Aneurysm rebleeding from clipped aneurysm

Rebleeding is an important cause of death and disability in people with aneurysmal subarachnoid hemorrhage. Rebleeding is probably related to dissolution of the blood clot at the site of aneurysm rupture by natural fibrinolytic activity.

For patients having an aneurysmal rupture after treatment, the mortality rate in the CARAT study was 58% 1).

Rebleeding is the most imminent danger.

Among patients surviving the initial hemorrhage treated without surgery, rebleeding is the major cause of morbidity and mortality, the risk is = 15-20% within 2 Weeks. The goal of early surgery is to reduce this risk.

Risk factors

Agitation, stress, unwarranted mobilization, straining, intramuscular injection, pain and fever can increase hemodynamic stress and predispose to rebleeding. Blood pressure (BP) management is crucial to prevent occurrence of stroke, reduce rebleeding, and maintain cerebral perfusion. Risk of rebleeding in the 1st 24 h is as high as 14%. A practical goal is to maintain systolic BP <160 mmHg till obliteration of aneurysm

Recognizing risk factors for aneurysmal rebleeding is particularly relevant and might help to identify the aneurysms that benefit from acute treatment 2)

Blood Pressure

Nicardipine, labetalol and sedation have been used to control hypertension. Almost 90% patients demonstrate some ECG changes attributable to neuro-cardiac response to sudden increase in ICP or intracranial bleed. These changes may be difficult to differentiate from that of myocardial ischemia. Severe arrhythmias (prolonged QT interval) and ischemic changes (ST changes) can result in increased hemodynamic complications, ischemic deficits, increased neurological intensive care unit (NICU) stay and mortality.

Hypotension can also occur after aSAH and is a manifestation of myocardial dysfunction. It manifests from excessive catecholamine levels and myocardial band necrosis and is seen with poor grade aSAH 3).

Challenges during anesthetic induction and intubation

General goals include smooth induction and hemodynamic control to prevent rebleeding. Propofol or thiopentone in liberal doses attenuates hemodynamic response and rebleeding risk in good grade patients. In poor grade patients with raised ICP, dose reduction is required as induction hypotension can compromise cerebral perfusion. Intubation should be smooth and swift to minimize hemodynamic stimulation as rupture of the aneurysm during intubation is associated with poor outcome.

Difficult intubation may be encountered when a large internal carotid artery (ICA) aneurysm protrudes into the oral cavity.

The risk from hemodynamic and hypoxic stress associated with repeated attempts at intubation can have an adverse bearing on the outcome 4).


Recurrent hemorrhage is highest within 24 hours of subarachnoid hemorrhage (SAH) and increases with the severity of the clinical grade, a recurrent hemorrhage can occur anytime after the initial SAH in patients with both good and poor clinical grades.

Park et al. adopted a 24-hour-a-day, formal protocol, emergency treatment strategy for patients with ruptured aneurysms to secure the aneurysms as early as possible. The incidences of in-hospital rebleeding and clinical outcomes were investigated and compared with those from previous years when broadly defined early treatment was used (< 3 days of SAH).

During an 11-year period, a total of 1224 patients with a ruptured aneurysm were managed using a strategy of broadly defined early treatment between 2001 and 2004 (Period B, n = 423), a mixture of early or emergency treatment between 2005 and 2007, and a formal emergency treatment protocol between 2008 and 2011 (Period A, n = 442). Propensity score matching was used to adjust the differences in age, sex, modified Fisher grade, World Federation of Neurosurgical Societies (WFNS) clinical grade at admission, size and location of a ruptured aneurysm, treatment modality (clip placement vs coil embolization), and time interval from SAH to admission between the two time periods. The matched cases were allotted to Group A (n = 280) in Period A and Group B (n = 296) in Period B and then compared.

During Period A under the formal emergency treatment protocol strategy, the catheter angiogram, endovascular coiling, and surgical clip placement were started at a median time from admission of 2.0 hours, 2.9 hours, and 3.1 hours, respectively. After propensity score matching, Group A showed a significantly reduced incidence of in-hospital rebleeding (2.1% vs 7.4%, p = 0.003) and a higher proportion of patients with a favorable clinical outcome (modified Rankin Scale score 0-3) at 1 month (87.9% vs 79.7%, respectively; p = 0.008). In particular, the patients with good WFNS grades in Group A experienced significantly less in-hospital rebleeding (1.7% vs 5.7%, respectively; p = 0.018) and better clinical outcomes (1-month mRS score of 0-3: 93.8% vs 87.7%, respectively; p = 0.021) than the patients with good WFNS grades in Group B.

Patients with ruptured aneurysms may benefit from a strategy of emergency application of surgical clip placement or endovascular coiling due to the reduced incidence of recurrent bleeding and improved clinical outcomes 5).


A meta-analysis was performed to evaluate whether an association could be determined between aneurysm diameter and the rebleeding rate before treatment. Potentially confounding factors such age, aneurysm location, and the presence of hypertension were also evaluated.

Boogaarts et al. systematically searched the PubMed, Embase, and Cochrane databases up to April 3, 2013, for studies of patients with aneurysmal subarachnoid hemorrhage that reported the association between aneurysm diameter and pretreatment aneurysmal rebleeding. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria were used to evaluate study quality.

Seven studies, representing 2121 patients, were included in the quantitative analysis. The quality of the studies was low in 2 and very low in 5. Almost all of the studies used 10 mm as the cutoff point for size among other classes, and only one used 7 mm. An analysis was performed with this best unifiable cutoff point. Overall rebleeding occurred in 360 (17.0%) of 2121 patients (incidence range, from study to study, 8.7%-28.4%). The rate of rebleeding in small and large aneurysms was 14.0% and 23.6%, respectively. The meta-analysis of the 7 studies revealed that larger size aneurysms were at a higher risk for rebleeding (OR 2.56 [95% CI 1.62-4.06]; p = 0.00; I 2 = 60%). The sensitivity analysis did not alter the results. Five of the 7 studies reported data regarding age; 4 studies provided age-adjusted results and identified a persistent relationship between lesion size and the risk of rebleeding. The presence of hypertension was reported in two studies and was more prevalent in patients with rebleeding in one of these. Location (anterior vs posterior circulation) was reported in 5 studies, while in 4 there was no difference in the rebleeding rate. One study identified a lower risk of rebleeding associated with posterior location aneurysms.

This meta-analysis showed that aneurysm size is an important risk factor for aneurysmal rebleeding and should be used in the clinical risk assessment of individual patients. The authors' results confirmed the current guidelines and underscored the importance of acute treatment for large ruptured aneurysms 6).

Case series


A total of 99 patients with aneurysmal rebleed were analyzed in this study both prospectively and retrospectively from August 2010 to July 2014. In the control group, 100 patients were selected randomly from the patient registry. A total of 25 variables from the demographic, historical, clinical and radiological data were compared and analyzed by univariate and multivariate logistic regression analysis.

Significant independent predictors of aneurysm rebleed were the presence of known hypertension (p = 0.023), diastolic blood pressure of >90 mmHg on admission (p = 0.008); presence of loss of consciousness (p = 0.013) or seizures (p = 0.002) at first ictus; history of warning headaches (p = 0.005); higher Fisher grade (p < 0.001); presence of multiple aneurysms (p = 0.021); irregular aneurysm surface (0.002).

Identification of high risk factors can help in stratifying patients in the high risk group. The risk stratification strategy with early intervention can prevent rebleeds. This in turn may translate into better outcomes of patients with intracranial aneurysms 7).

Johnston SC, Dowd CF, Higashida RT, Lawton MT, Duckwiler GR, Gress DR: Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) study. Stroke 39:120–125, 2008
Connolly ES, Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012;43:1711–37.
Naidech AM, Kreiter KT, Janjua N, Ostapkovich ND, Parra A, Commichau C, et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005;112:2851–6.
Sriganesh K, Venkataramaiah S. Concerns and challenges during anesthetic management of aneurysmal subarachnoid hemorrhage. Saudi J Anaesth. 2015 Jul-Sep;9(3):306-13. doi: 10.4103/1658-354X.154733. Review. PubMed PMID: 26240552; PubMed Central PMCID: PMC4478826.
Park J, Woo H, Kang DH, Kim YS, Kim MY, Shin IH, Kwak SG. Formal protocol for emergency treatment of ruptured intracranial aneurysms to reduce in-hospital rebleeding and improve clinical outcomes. J Neurosurg. 2014 Nov 18:1-9. [Epub ahead of print] PubMed PMID: 25403841.
Boogaarts HD, van Lieshout JH, van Amerongen MJ, de Vries J, Verbeek AL, Grotenhuis JA, Westert GP, Bartels RH. Aneurysm diameter as a risk factor for pretreatment rebleeding: a meta-analysis. J Neurosurg. 2015 Apr;122(4):921-8. doi: 10.3171/2014.12.JNS14931. Epub 2015 Feb 6. PubMed PMID: 25658785.
Solanki C, Pandey P, Rao KV. Predictors of aneurysmal rebleed before definitive surgical or endovascular management. Acta Neurochir (Wien). 2016 Jun;158(6):1037-44. doi: 10.1007/s00701-016-2784-6. Epub 2016 Apr 11. PubMed PMID: 27068042.
intracranial_aneurysm_rebleeding.txt · Last modified: 2018/01/02 22:43 by administrador